Funding Atlas demonstration
Illustrative programme verdicts Available Profile A screens 88 source-checked Atlas records.
13 separate Current Reference records have no eligibility verdict.
Change a control to rerun the published engine for screened records.
Release boundary Source records checked as of 3 October 2026. Official source links remain attached to every verdict. Pinned illustrations
Start from a documented illustrative profile Profile AIllustrative UK biotech, not a real applicant. Profile BIllustrative Austrian GmbH, not a real applicant. Profile CIllustrative Delaware corporation, not a real applicant.
Screening result for an illustrative UK biotech profile, Funding Atlas v0.6, as of 3 October 2026. Not a real applicant.
The selected programme does not alter profile inputs. This is a rule-screening illustration, not a funding decision or an award promise.
Profile controls Entity type Sme Large Academic Hospital Nonprofit Country Albania Armenia Austria Australia Albania Bosnia and Herzegovina Belgium Bulgaria Bosnia and Herzegovina Canada Switzerland Cyprus Czechia Germany Denmark Estonia Spain EU Member States EU Member States (including outermost regions) Finland Faroe Islands France Georgia Greece Georgia Croatia Hungary Horizon Europe associated countries Ireland Israel Iceland Italy Iceland South Korea Kingdom of the Netherlands Kosovo Lithuania Luxembourg Latvia Liechtenstein Moldova Montenegro North Macedonia Malta Moldova Montenegro Netherlands Norway New Zealand Non-U.S. entities subject to applicable requirements; entities organized under the laws of covered foreign countries are ineligible North Macedonia Norway Overseas Countries and Territories (OCTs) Overseas Countries and Territories linked to EU Member States Poland Portugal Romania Serbia Sweden Singapore Slovenia Slovakia Serbia Tunisia Türkiye U.S. territories/possessions Ukraine United Kingdom United States Ukraine United States Worldwide except China (including Hong Kong) Kosovo South Africa certain low- and middle-income countries international non-U.S. other third countries eligible for EU4Health at the time of award Size class Use fixture financials Micro, evidence needed Small, evidence needed Medium, evidence needed Large, evidence needed Not supplied Stage Discovery Preclinical Phase1 Phase2 Phase3 Market Sector Psychiatry Neurology Oncology Cardiovascular Infectious Disease Rare Disease Any Ownership Use fixture ownership facts Majority US, evidence needed Foreign parent, evidence needed Not supplied Controls need JavaScript. Profile A results remain available below.
Live engine verdicts
Source-linked programme checks
Fits 3
Conditions 31
Does not fit 51 3 policy/designation source records are neutral context, not funding opportunities; they are excluded from funding-fit counts.
Profile A verdicts are final server results from the published engine.
Does not fit AT-AWS-DOUBLE
aws Guarantee - Equity Leverage Source title note current specific terms; historical Double Equity
aws (Austria Wirtschaftsservice)
Engine reason Covers on-market stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is market.
The explicit counterfactual improves 6 funding programme levels.
Official programme source Does not fit AT-FFG-BP
Basisprogramm Source title note general programme
FFG
Engine reason Covers discovery, preclinical, on-market stages.
Source check: Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Fits AT-FFG-LS
Austrian Life Sciences 2024 to 2026: clinical studies Source title note Phase I and II
FFG (Austrian Research Promotion Agency)
Engine reason Apply through your entity in Austria.
Source check: Sep 2026
Official programme source Does not fit AT-FWF-KLIF
Clinical research programme Source title note KLIF
FWF (Austrian Science Fund)
Engine reason Applicants must be universities or research institutes or hospitals.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Fits with conditions AT-WAW
Innovation Source title note 2024-2026
Vienna Business Agency (Wirtschaftsagentur Wien)
Engine reason Confirm gber eligibility and applicable aid limits with the funder.
Source check: 2 Oct 2026
Official programme source Fits with conditions AU-CRCP
Cooperative Research Centres Projects Source title note CRC-P
Department of Industry
Engine reason Needs an entity incorporated in AU.
Source check: 30 Sep 2026
Official programme source Does not fit AU-MRCF
Venture investment in biomedical technologies associated with Brandon BioCatalyst Member Institutes Brandon BioCatalyst (formerly the Medical Research Commercialisation Fund), managed by Brandon Capital
Engine reason Applicants must be universities or research institutes or hospitals.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Does not fit AU-MRFF
MRFF grant opportunities Source title note Million Minds Mental Health Research Mission; Clinical Trials Activity Initiative including International Clinical Trial Collaborations
Medical Research Future Fund
Engine reason Applicants must be universities or research institutes or hospitals or non-profits.
Source check: 30 Sep 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Does not fit AU-MRFF-ICTC
International Clinical Trial Collaborations Medical Research Future Fund, Clinical Trials Activity Initiative
Engine reason Applicants must be universities or research institutes or hospitals or non-profits.
Source check: 30 Sep 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Fits with conditions AU-RDTI
R&D Tax Incentive Australian Taxation Office and AusIndustry
Engine reason Eligible corporation must be Australian-incorporated, Australian tax resident, or a qualifying treaty-country company operating through an Australian permanent establishment. Actual offset and refundability depend on company rate and R&D intensity.
Source check: 2 Oct 2026
Official programme source Does not fit CA-CIHR
Project Grant Canadian Institutes of Health Research
Engine reason Applicants must be universities or research institutes or hospitals.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Fits with conditions CA-IRAP
NRC IRAP advisory services and funding National Research Council of Canada
Engine reason Needs an entity incorporated in CA.
Source check: 2 Oct 2026
Official programme source Does not fit CA-MITACS
Accelerate Source title note industry-matched research internships
Mitacs
Engine reason Covers discovery, preclinical, Phase 1 stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Neutral CH-TAX
Patent box and additional R&D deduction Source title note cantonal
Swiss cantons
Neutral classification This policy/designation record is source-linked Atlas context, not a funding opportunity. It is excluded from funding-fit results.
Source check: 2 Oct 2026
Official programme source Does not fit DE-DFG-KS
Clinical Trials Programme Source title note investigator-initiated clinical trials
Deutsche Forschungsgemeinschaft (DFG)
Engine reason Applicants must be universities or research institutes or hospitals or non-profits.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Does not fit DE-EKFS
ForTra Translational Research Else Kroener-Fresenius-Stiftung
Engine reason Applicants must be universities or research institutes or hospitals.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Fits with conditions DE-FZ
Forschungszulage Source title note research allowance
German Federal Government
Engine reason Needs an entity incorporated in DE.
Source check: 30 Sep 2026
Official programme source Does not fit DE-KMUI
KMU-innovativ: Biomedizin German Federal Ministry of Research, Technology and Space (BMFTR, formerly BMBF), through Projektträger Jülich
Engine reason Covers discovery, preclinical, Phase 1 stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Fits with conditions DE-KMUI-MT
KMU-innovativ: Medizintechnik German Federal Ministry of Research, Technology and Space (BMFTR)
Engine reason Needs an entity incorporated in DE.
Source check: 30 Sep 2026
Official programme source Does not fit DK-LUNDBECK
LF Fellows Lundbeck Foundation
Engine reason Applicants must be universities or research institutes or hospitals.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Fits EU-EIC-ACC
EIC Accelerator Source title note grant up to EUR 2.5m plus investment up to EUR 10m; EUR 15m for strategic technologies
European Innovation Council
Engine reason SME status confirmed (micro enterprise).
Source check: 30 Sep 2026
Official programme source Does not fit EU-EIC-PF
EIC Pathfinder Open and Pathfinder Challenges Source title note 2026 challenge topics include Biotechnology for Healthy Ageing
European Innovation Council
Engine reason Covers discovery, preclinical stages.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Does not fit EU-EIC-TR
EIC Transition European Innovation Council
Engine reason Covers preclinical, Phase 1 stages.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is preclinical.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Fits with conditions EU-EIT-HEALTH-TTO-2026
Technology Transfer Offices & Entrepreneurship Support Call EIT Health
Engine reason Consortium required: Required: a consortium of 3-4 independent legal entities, with at least two legally established in different Horizon Europe countries; at least two Technology Transfer Offices representing higher-education institutions or research organisations; and at least one Entrepreneurship Support Provider with venture-building and start-up-support experience..
Source check: 2 Oct 2026
Official programme source Does not fit EU-ERC-POC
ERC Proof of Concept European Research Council
Engine reason Applicants must be universities or research institutes.
Source check: 30 Sep 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Fits with conditions EU-EU4H-2026-OP-0020
EU4Health - Capacity reservation for personal protective equipment pilot Source title note EU FAB+ PPE pilot
European Health and Digital Executive Agency (HaDEA) / European Commission
Engine reason Tender through the EU electronic submission system and register each participating economic operator in the European Commission Participant Register.
Source check: 2 Oct 2026
Official programme source Fits with conditions EU-EUROSTARS
Eurostars Call 12 Source title note national co-funding through each country's agency
Eureka, Eurostars 3
Engine reason Consortium required: Innovative SME lead from a Eurostars country; at least two independent partners from two Eurostars countries.
Source check: 30 Sep 2026
Official programme source Fits with conditions EU-HE-HLTH-C02
HORIZON-HLTH-2027-01-CARE-02 personalised approaches to reduce risks from adverse drug reactions due to multiple medications European Commission, Horizon Europe Cluster 1
Engine reason Consortium required: Consortium of at least three independent legal entities from three eligible countries, at least one in an EU member state.
Source check: 1 Oct 2026
Official programme source Fits with conditions EU-HE-HLTH-D01
HORIZON-HLTH-2027-02-DISEASE-01 innovative interventions for non-communicable diseases European Commission, Horizon Europe Cluster 1
Engine reason Consortium required: 3 partners, 3 countries.
Source check: 1 Oct 2026
Official programme source Does not fit EU-HE-HLTH-D05
HORIZON-HLTH-2027-01-DISEASE-05 novel small-molecule antiviral therapeutics for pathogens with epidemic potential European Commission, Horizon Europe Cluster 1
Engine reason Covers discovery, preclinical, Phase 1 stages.
Source check: 1 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Does not fit EU-HE-HLTH-D08
HORIZON-HLTH-2027-01-DISEASE-08 innovative antimicrobials against antimicrobial-resistant pathogens European Commission, Horizon Europe Cluster 1
Engine reason Covers discovery, preclinical, Phase 1 stages.
Source check: 1 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Fits with conditions EU-HE-HLTH-D10
HORIZON-HLTH-2027-01-DISEASE-10 prevention and management of chronic non-communicable diseases in children and young people Source title note GACD
European Commission, Horizon Europe Cluster 1
Engine reason Consortium required: Consortium of at least three independent legal entities from three eligible countries, at least one in an EU member state.
Source check: 1 Oct 2026
Official programme source Does not fit EU-HE-HLTH-D14
HORIZON-HLTH-2027-02-DISEASE-14 clinical trials in neurodegenerative diseases European Commission, Horizon Europe Cluster 1
Engine reason Scope limited to neurology, cns.
Source check: 1 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Does not fit EU-HE-HLTH-E02
HORIZON-HLTH-2027-01-ENVHLTH-02 integrating climate-related exposures into the human exposome European Commission, Horizon Europe Cluster 1
Engine reason Covers discovery stages.
Source check: 1 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Does not fit EU-HE-HLTH-I01
HORIZON-HLTH-2027-01-IND-01 cell-free protein synthesis platforms for discovery and production of biologicals European Commission, Horizon Europe Cluster 1
Engine reason Covers discovery, preclinical stages.
Source check: 1 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Fits with conditions EU-HE-HLTH-I02
HORIZON-HLTH-2027-02-IND-02 portable and versatile point-of-care diagnostics European Commission, Horizon Europe Cluster 1
Engine reason Consortium required: Consortium of at least three independent legal entities from three eligible countries, at least one in an EU member state.
Source check: 1 Oct 2026
Official programme source Fits with conditions EU-HE-HLTH-I03
HORIZON-HLTH-2026-01-IND-03 regulatory science to support translational development of patient-centred health technologies European Commission, Horizon Europe Cluster 1
Engine reason Consortium required: Consortium of at least three independent legal entities from three eligible countries, at least one in an EU member state.
Source check: 1 Oct 2026
Official programme source Fits with conditions EU-HE-HLTH-S01
HORIZON-HLTH-2027-01-STAYHLTH-01 addressing disabilities through the life course to support independent living and inclusion European Commission, Horizon Europe Cluster 1
Engine reason Consortium required: Consortium of at least three independent legal entities from three eligible countries, at least one in an EU member state.
Source check: 1 Oct 2026
Official programme source Fits with conditions EU-HE-HLTH-T01
HORIZON-HLTH-2027-02-TOOL-01 predictive biomarkers of disease progression and treatment response using AI for chronic non-communicable diseases European Commission, Horizon Europe Cluster 1
Engine reason Consortium required: Consortium of at least three independent legal entities from three eligible countries, at least one in an EU member state.
Source check: 1 Oct 2026
Official programme source Does not fit EU-STEP
EIC STEP Scale Up European Innovation Council
Engine reason Covers on-market stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is market.
The explicit counterfactual improves 6 funding programme levels.
Official programme source Does not fit FR-ANR-PRCE
PRCE collaborative research projects between public labs and companies Agence Nationale de la Recherche (ANR)
Engine reason Covers discovery, preclinical stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Does not fit GL-CARBX
CARB-X funding rounds for early-stage antibacterial products CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator, Boston University)
Engine reason Covers discovery, preclinical, Phase 1 stages.
Source check: 1 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Does not fit IE-EI
Disruptive Technologies Innovation Fund - Call 8 Source title note DTIF
Department of Enterprise, Tourism and Employment (DETE), administered by Enterprise Ireland
Engine reason Only applicants established in IE can apply.
Source check: 2 Oct 2026
Rule-fail remedy Use an eligible applicant country or structure only where the official programme terms permit it.
Counterfactual: applicant country is Ireland.
The explicit counterfactual improves 1 funding programme levels.
Official programme source Fits with conditions IE-RDTC
R&D Corporation Tax Credit Irish Revenue
Engine reason The claimant must be a company within the charge of Corporation Tax in Ireland; it must carry out qualifying R&D in Ireland, the EEA or the UK, and the expenditure must not qualify for a tax deduction in another country.
Source check: 2 Oct 2026
Official programme source Does not fit NL-IBOX
Innovation box Source title note reduced corporate tax on qualifying innovation profits
Dutch Tax Administration
Engine reason Covers on-market stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is market.
The explicit counterfactual improves 6 funding programme levels.
Official programme source Fits with conditions NL-IK
Innovatiekrediet Source title note Innovation Credit
RVO
Engine reason Needs an entity incorporated in NL.
Source check: 30 Sep 2026
Official programme source Does not fit NL-ZONMW-GGG
Geneesmiddelen VIMP 2026-1 Source title note under Goed Gebruik Geneesmiddelen (GGG)
ZonMw
Engine reason Only applicants established in Kingdom of the Netherlands can apply.
Source check: 2 Oct 2026
Rule-fail remedy Use an eligible applicant country or structure only where the official programme terms permit it.
Counterfactual: applicant country is Kingdom of the Netherlands.
The explicit counterfactual improves 1 funding programme levels.
Official programme source Does not fit NO-RCN
Innovation project in the industrial sector: Energy and transport 2026 Research Council of Norway
Engine reason Only applicants established in NO can apply.
Source check: 2 Oct 2026
Rule-fail remedy Use an eligible applicant country or structure only where the official programme terms permit it.
Counterfactual: applicant country is Norway.
The explicit counterfactual improves 1 funding programme levels.
Official programme source Fits with conditions PL-TAX
R&D relief Source title note ulga B+R
Polish Ministry of Finance
Engine reason Qualifying costs must not have been reimbursed in any form and must not also be deducted from the tax base.
Source check: 2 Oct 2026
Official programme source Does not fit SG-STARTUPSG
Startup SG Tech Source title note proof of concept and proof of value grants
Enterprise Singapore
Engine reason Covers discovery, preclinical stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Fits with conditions UK-EME
Efficacy and Mechanism Evaluation Source title note EME
NIHR and MRC
Engine reason Proposal must fit the EME remit and demonstrate a reliable, peer-reviewed proof-of-concept signal in humans.
Source check: 2 Oct 2026
Official programme source Fits UK-ERIS
R&D tax relief: Enhanced R&D Intensive Support for loss-making R&D-intensive SMEs, and the merged scheme Source title note ERIS; RDEC
HM Revenue and Customs
Engine reason R&D intensity 85% qualifies for ERIS if the company is loss-making.
Source check: 30 Sep 2026
Official programme source Fits with conditions UK-FFB
Future Fund: Breakthrough Source title note equity co-investment
British Business Bank
Engine reason Consortium required: Funding applications can only be made by a qualifying sponsor investor..
Source check: 2 Oct 2026
Official programme source Fits with conditions UK-I4I
Invention for Innovation Product Development Awards Source title note i4i
NIHR
Engine reason Medical devices, in vitro diagnostics and digital health technologies only; medicines are outside the i4i remit.
Source check: 30 Sep 2026
Official programme source Neutral UK-ILAP
Innovative Licensing and Access Pathway Source title note Innovation Passport
MHRA
Neutral classification This policy/designation record is source-linked Atlas context, not a funding opportunity. It is excluded from funding-fit results.
Source check: Sep 2026
Official programme source Fits with conditions UK-KTP
Knowledge Transfer Partnerships Innovate UK
Engine reason Consortium required: The UK-registered knowledge base must lead and apply with a UK-registered business (with two or more full-time-equivalent employees), supported by an Innovate UK-appointed Knowledge Transfer Adviser..
Source check: 2 Oct 2026
Official programme source Does not fit UK-LIFEARC-RDCTP-2026
Rare Disease Clinical Trials Programme LifeArc
Engine reason Scope limited to rare.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is rare.
The explicit counterfactual improves 3 funding programme levels.
Official programme source Does not fit UK-MRC-DPFS
MRC Proof of Concept Source title note formerly the Developmental Pathway Funding Scheme
Medical Research Council
Engine reason Applicants must be universities or research institutes.
Source check: 30 Sep 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Does not fit UK-MRC-IAA
MRC Impact Acceleration Award Source title note formerly the MRC Gap Fund
Medical Research Council (UKRI)
Engine reason Applicants must be universities or research institutes.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Does not fit UK-PATENTBOX
Patent Box HM Revenue and Customs
Engine reason Covers on-market stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is market.
The explicit counterfactual improves 6 funding programme levels.
Official programme source Does not fit US-ADDF
Drug Development RFP Source title note venture philanthropy / mission-related investment
Alzheimer's Drug Discovery Foundation
Engine reason Scope limited to neurology.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Does not fit US-ALZ-AARG
Alzheimer's Association Research Grant For All Program Source title note AARGA
Alzheimer's Association
Engine reason Applicants must be universities or research institutes or hospitals or non-profits.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Does not fit US-ALZ-PTC
Part the Cloud clinical trial funding Alzheimer's Association
Engine reason Scope limited to neurology.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Does not fit US-ARPAH-HSF-ISO-24-104
Health Science Futures Mission Office Innovative Solutions Opening, ARPA-H-SOL-24-104 Source title note HSF; ISO; Amendment 03
ARPA-H
Engine reason Covers discovery, preclinical stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is discovery.
The explicit counterfactual improves 9 funding programme levels.
Official programme source Fits with conditions US-CDMRP-ARP
Autism Research Program Source title note ARP
CDMRP
Engine reason A military or veteran relevance statement is required; topic areas change each fiscal year.
Source check: 30 Sep 2026
Official programme source Does not fit US-CDMRP-ASUD
Alcohol and Substance Use Disorders Research Program Source title note ASUDRP
CDMRP
Engine reason Scope limited to addiction.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is addiction.
The explicit counterfactual improves 2 funding programme levels.
Official programme source Does not fit US-CDMRP-ERP
Epilepsy Research Program Source title note ERP
CDMRP
Engine reason Scope limited to neurology.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Does not fit US-CDMRP-PRARP
Alzheimer's Research Program Source title note AZRP; formerly PRARP
CDMRP
Engine reason Scope limited to neurology.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Fits with conditions US-CDMRP-PRMRP
Peer Reviewed Medical Research Program: Clinical Trial Awards and others Source title note PRMRP
CDMRP (Department of Defense)
Engine reason An IND or equivalent regulatory application must be submitted by the application deadline.
Source check: 30 Sep 2026
Official programme source Does not fit US-CDMRP-PRP
Parkinson's Research Program Source title note PRP
CDMRP
Engine reason Scope limited to neurology.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Fits with conditions US-CDMRP-TBIPH
Traumatic Brain Injury and Psychological Health Research Program Source title note TBIPHRP
CDMRP
Engine reason A military or veteran relevance statement is required; topic areas change each fiscal year.
Source check: 30 Sep 2026
Official programme source Does not fit US-CHDI
Collaborative research on Huntington's disease CHDI Foundation
Engine reason Applicants must be universities or research institutes.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Fits with conditions US-CIRM
Clinical Trial Awards Source title note CLIN2
California Institute for Regenerative Medicine
Engine reason Propose an interventional phase 1, 2, or 3 clinical trial for a stem cell-based or genetic therapy.
Source check: 2 Oct 2026
Official programme source Does not fit US-CPRIT-R-27-2-CFSA
Core Facility Support Award Source title note RFA R-27.2-CFSA
Cancer Prevention and Research Institute of Texas
Engine reason Applicants must be universities or research institutes.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Does not fit US-FDA-OPD
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases Source title note RFA-FD-25-020, R01
FDA Office of Orphan Products Development
Engine reason Scope limited to rare.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is rare.
The explicit counterfactual improves 3 funding programme levels.
Official programme source Does not fit US-FDA-OPD-NH
Efficient and Innovative Natural History Studies in Rare Diseases Source title note RFA-FD-25-017
FDA Office of Orphan Products Development
Engine reason Scope limited to rare.
Source check: 30 Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is rare.
The explicit counterfactual improves 3 funding programme levels.
Official programme source Does not fit US-MJFF
Parkinson's Disease Therapeutics Pipeline Program Source title note TPP
The Michael J. Fox Foundation
Engine reason Scope limited to neurology.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Does not fit US-NCATS-PAR-25-450
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes Source title note R21 Clinical Trial Not Allowed
NIH NCATS
Engine reason Only applicants established in United States, U.S. territories/possessions can apply.
Source check: 2 Oct 2026
Rule-fail remedy Use an eligible applicant country or structure only where the official programme terms permit it.
Counterfactual: applicant country is United States.
The explicit counterfactual improves 0 funding programme levels.
Official programme source Does not fit US-NEURONEXT
NeuroNEXT Source title note Phase 2 clinical trials network in neurology
NIH NINDS
Engine reason Scope limited to neurology.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is neurology.
The explicit counterfactual improves 8 funding programme levels.
Official programme source Does not fit US-NIDA-UG3
PAR-25-446 Clinical trials of medications for substance use disorders Source title note UG3/UH3
NIH National Institute on Drug Abuse
Engine reason Scope limited to addiction.
Source check: Sep 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: sector is addiction.
The explicit counterfactual improves 2 funding programme levels.
Official programme source Neutral US-NIH-FOREIGN
Policy note: foreign subawards not permitted from 1 May 2025; international project components Source title note NOT-OD-25-104; NOT-OD-25-155
NIH
Neutral classification This policy/designation record is source-linked Atlas context, not a funding opportunity. It is excluded from funding-fit results.
Source check: Sep 2026
Official programme source Fits with conditions US-NIMH-R33
PAR-25-183 Confirmatory efficacy trials Source title note R33
NIH NIMH
Engine reason An open or submitted IND is required at application.
Source check: Sep 2026
Official programme source Fits with conditions US-NIMH-R61
PAR-25-184 Clinical trials to test the therapeutic potential of pharmacological interventions Source title note R61/R33
NIH National Institute of Mental Health
Engine reason An open or submitted IND is required at application.
Source check: Sep 2026
Official programme source Fits with conditions US-NIMH-U01
PAR-25-180 Industry-academic partnerships for pharmacological interventions Source title note U01
NIH NIMH
Engine reason An open or submitted IND is required at application.
Source check: Sep 2026
Official programme source Does not fit US-NSF-SBIR
America's Seed Fund Source title note SBIR/STTR
National Science Foundation
Engine reason Only applicants established in United States can apply.
Source check: 2 Oct 2026
Rule-fail remedy Use an eligible applicant country or structure only where the official programme terms permit it.
Counterfactual: applicant country is United States.
The explicit counterfactual improves 0 funding programme levels.
Official programme source Does not fit US-PCORI
Broad Pragmatic Studies PCORI Funding Announcement - Cycle 1 2027 Source title note BPS
PCORI
Engine reason Covers on-market stages.
Source check: 2 Oct 2026
Rule-fail remedy Confirm that the proposed work genuinely falls within the official scope before applying.
Counterfactual: development stage is market.
The explicit counterfactual improves 6 funding programme levels.
Official programme source Fits with conditions US-RDCREDIT
Federal research credit with payroll-tax offset for qualified small businesses Source title note Section 41
Internal Revenue Service
Engine reason Make the annual payroll-tax credit election on Form 6765 by the due date of the originally filed income-tax return, including extensions; it cannot be made on an amended return.
Source check: 2 Oct 2026
Official programme source Does not fit US-SFARI-NEW-IDEAS-2026
New Ideas - Request for Applications Simons Foundation Autism Research Initiative
Engine reason Applicants must be universities or research institutes or hospitals or non-profits.
Source check: 2 Oct 2026
Rule-fail remedy Partner with an eligible academic or hospital applicant; supply product, data or co-funding.
Counterfactual: applying entity is academic.
The explicit counterfactual improves 7 funding programme levels.
Official programme source Controls require JavaScript. The Profile A verdicts shown here are server-rendered from the release-locked engine.
Current Reference records These programmes were confirmed on an official page but lack published fields or encoded rules. They are not included in the Atlas figures, 90-day deadlines, or the fit verdict counts. A Reference record without encoded rules reads “Rules not yet encoded”, never “Does not fit”.
Austrian Federal Ministry of Finance · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page CSIRO · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Canada Revenue Agency · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Innosuisse · Current Reference · Official page checked 2 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Lundbeckfonden BioCapital · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page European Investment Bank · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Innovative Health Initiative (IHI JU) · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Business Finland · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page French tax administration · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Dementia Discovery Fund (managed by SV Health Investors) · Current Reference · Official page checked 2 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Scottish Enterprise · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page NIH National Center for Complementary and Integrative Health · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page Internal Revenue Service · Current Reference · Official page checked 3 October 2026. Individual award maximum: Not published. Rules not yet encoded.
Official funder page